Monday, September 18, 2006

Fingolimod


Fingolimod

New treatment offers big hope to MS patients
CTV.ca - Canada
Research on Phase II trials of a new drug called fingolimod, published in the New England Journal of Medicine, shows promising results for patients being able ...




You beauty! City pioneers use Botox to fix bladder problems
The Scotsman Mon, 18 Sep 2006 6:21 AM PDT
PIONEERING surgeons are using the beauty treatment Botox to cure bladder problems in multiple sclerosis sufferers.

New treatment offers big hope to MS patients
CTV.ca Sun, 17 Sep 2006 7:33 PM PDT
A small pill is offering big hope -- and fewer needles -- to many of the 55,0000 Canadians with multiple sclerosis who depend on injections and intravenous treatment.

Bid to Stockpile Bioterror Drugs Stymied by Setbacks
New York Times Sun, 17 Sep 2006 9:14 PM PDT
Project BioShield, a $5.6 billion effort to expand the nation?s medical stockpile, has largely failed to deliver, critics say.

Peroxide sellers to lay off the health promises
Fort Worth Star-Telegram Mon, 18 Sep 2006 5:28 AM PDT
The FDA cracks down on claims that hydrogen peroxide can treat AIDS, cancer and other conditions.

Susan Yerkes: MS official sporting red for a good cause
San Antonio Express News Sun, 17 Sep 2006 10:15 PM PDT
Last Tuesday, Tony Ralf got a spectacular dye job — for a cause.

Opexa Therapeutics Begins Phase IIb Multiple Sclerosis Study ...
Trading Markets - Los Angeles,CA,USA
(OPXA | charts | news | PowerRating), a developer of cell therapies, announced that it has started its Phase IIb study with Tovaxin for the treatment of ...
See all stories on this topic

Tysabri

Analysis: Colitis market to hit $1.1B
United Press International - USA
... Lai said the drug is similar to Elan/Biogen Idec's multiple sclerosis treatment Tysabri, which was temporarily taken off the market when it was found to ...



0 Comments:

Post a Comment

<< Home